Three Village Infusions, division of Three Village Allergy & Asthma, uses a variety of intravenous and subcutaneous medicines via infusion pumps to treat patients in Long Island. We have capabilities to infuse medications for neurologic, gastrointestinal, rheumatologic, pulmonary and immunologic and immunodeficiency disease. With our expert nursing team and medical staff, we care for patients in a comfortable setting with reclining leather chairs, Wi-Fi and tablets. See a list of our available treatments here.
About Dr Szema
Anthony Szema, MD is the Founder and President of Three Village Infusions, Division of Three Village Allergy & Asthma, PLLC, in partnership with McKesson Corporation. We are a full-service multi-specialty infusion center.
Anthony M. Szema, MD, FCCP, FAAAAI, FACAAI, FACP, ATSF is Clinical Professor of Medicine (Pulmonary/Critical Care and Clinical Adult and Pediatric Allergy/Immunology) and Clinical Professor of Occupational Medicine, Epidemiology, and Prevention, Director, International Center of Excellence in Deployment Health and Medical Geosciences, Northwell Health Foundation, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Szema is a Research Assistant Professor, College of Engineering and Applied Sciences, Department of Technology and Society, Stony Brook University.
Education
Dr. Szema received his undergraduate degree in Industrial and Management Engineering from Rensselaer Polytechnic Institute (RPI), Troy, NY, his medical degree from Albany Medical College, Albany, NY, medicine training at Johns Hopkins Bayview Medical Center, There he was fellow in medicine at Johns Hopkins University School of Medicine, Hahnemann University Hospital, and fellowships in pulmonary/critical care/clinical adult and pediatric allergy/immunology and postdoctoral rheumatology/immunology research at New York Presbyterian Hospital Columbia University Campus. He was past Allergy/Immunology fellowship director at Stony Brook University and Section Head at the University and the Veterans Affairs Medical Center, Northport, NY. When he was fellowship director, his fellows had the highest allergy immunology in-service examination scores in the United States. He was awarded the teaching award from the internal medicine house staff at Stony Brook University Medical Center.
Current Work
Szema has been a member of the American Thoracic Society (ATS) since 1994 and a member of the Section on Terrorism and Inhalation Disasters since its founding and is current Chair. He is a Harvard Macy Scholar. He received the 2024 Scientific Excellence in Mentorship Award from the Dean, David Battinelli, MD, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, “for high quality dedication, hard work, guidance, and overall mentorship efforts in support of Zucker School of Medicine students participating in Northwell Health Research.”
He is a co-investigator on a $3.5 million DOD grant to develop wearable air pollution and bioterrorism gas monitoring devices, study mouse models with mock burn pits chambers, and verify real-world efficacy of miniaturized devices using portable impulse oscillometry in firefighters to model soldiers in combat. Dr. Szema hosts a weekly Zoom group with pulmonologists and students from across the US, including his mentor Dr. Robert Promisloff, FCCP, from Drexel University College of Medicine.
He is funded by the NIH and CDC NIOSH with the Columbia University Global Psychiatric Epidemiology Group (GPEG) for studies of children exposed to the disaster of the World Trade Center. His team was the first to describe pediatric asthma rate acceleration and persistent lung injury in New York City’s Chinatown post 9/11; and ongoing studies are the first federally-funded grants to investigate long-term mind-body damage with immunological and pulmonary mechanisms of harm and resilience. Author of five books, World Trade Center Pulmonary Diseases and Multi-Organ System Manifestations is the first textbook on the subject. Szema’s students are concerned about young adults “hotboxing” and utilize the NIH NCI SEER CRWDi database to actively study vaping, ARDS, and COVID-19 pneumonia.
Mentoring
Dr. Anthony Szema has a longstanding interest in mentoring minority lower socioeconomic strata premedical students and has assisted one hundred first generation premedical students who have gone on to medical school, as detailed in 15 Secrets for Getting into first generation Medical School: Go to Yale Without Going to Jail (amazon). He has been a member of medical school admission and undergraduate pre-medical committees and actively mentors premedical students and medical students working in his office, who most recently presented ten abstracts at the ATS 2025 San Francisco International Conference.
He is deeply committed to the ATS mission, having been mentored since high school via a Northeastern NY American Lung Association (ALA) Mini Externship/Scholarship by the late Johns Hopkins-trained pulmonologist Professor Robert E. Dutton, Jr., MD, from Rensselaer Polytechnic Institute’s (RPI) Department of Biomedical Engineering and Albany Medical College’s Departments of Medicine and Physiology, and later by the ATS Amberson Lecturer, Distinguished SUNY Professor Sami I. Said, MD, the discoverer of Vasoactive Intestinal Peptide (VIP). Dr. Said was Dr. Szema’s NIH NHLBI K08 mentor studying spontaneous airway inflammation and hyperresponsiveness in VIP knockout Mice as a model of asthma. Szema co-invented a candidate drug which reverses lung fibrosis from bleomycin in mice and founded the start-up company RDS2 Solutions, Inc. to commercialize intellectual property.
Work on Burn Pits
Szema first reported new-onset allergic rhinitis and asthma (presented at CHEST Toronto) with deployment to Iraq and coined the term Iraq Afghanistan War Lung Injury (IAW-LI), for which he initially testified before the U.S. Senate Democratic Policy Committee in 2009 and the U.S. Senate Veterans Affairs Committee in March 2021, in support of presumptive benefits for warfighters deployed to Iraq and Afghanistan with exposure to airborne hazards such as burn pits. He served as an expert witness before the U.S. Senate Armed Services Committee March 16, 2022, to discuss recommendations for force health protection from burn pits and airborne hazards of war. Advocating with Veterans, their families, colleagues, and Jon Stewart and burnpits360, his premedical students prepared a document for Senators which led to over a dozen bipartisan bills supporting soldiers that led to the passage of the $450 Billion PACT ACT signed by President Biden for which he was invited to the White House for its signing August 10, 2022. This is the largest expansion of the VA since its founding by Abraham Lincoln.
Szema was part of the Distinguished Speakers Series at Harvard Law School February 16, 2022, on the topic of Burn Pits and Veterans Health Presumption with Senator Kirsten Gillibrand. The Medical Society of the State of New York awarded him the Albion O. Bernstein Award “For his life-long commitment to the field of allergy, asthma, immunology and pulmonary diseases and his dedication to the health of American servicemen and women 9-12-13.” President Obama signed the Open-Air Burn Pit Registry law based on a bill from Congressman Tim Bishop who cited his team’s research in discovering the disease, characterizing clinical phenotype, making animal models, and designing therapeutic agents. He is funded by the Department of Defense for animal models and clinical research regarding burn pits. His team’s recent paper in Scientific Reports shows jet fuel JP-8 and polycyclic aromatic hydrocarbons in lung tissue from burn pit exposed Veterans is associated with airways hyperresponsiveness and distal airways narrowing by impulse oscillometry, which is not detectable by spirometry.
The Reserve Organization of American (ROA), formerly Reserve Officers Association, awarded Szema the 2022 Twice the Citizen Award for his role in the June 29, 2022, Torres V. Texas Department of Public safety US Supreme Court Victory that strengthened the effect of federal Uniformed Services Employment and Reemployment Rights Act (USERRA) law for all members of the Reserve Components. He is the 2024 Suffolk County, NY, Health Care Hero selected by the Suffolk County Legislature and was a participant in the Harvard Radcliffe Institute Exploratory Seminar on Veterans Health and Toxic Exposures, December 2024.